Evaluation of the Safety and Efficacy of Autologous COVID-19 Antigen Specific T Cell in Prolonged SARS-CoV-2 Patients

Clinical trial NCT07690943 · COMPLETED

Trial details

NCT number: NCT07690943
Sponsor: LucasBio
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

COVID-19 COVID-19 (SARS-CoV-2 Infection)

Start date: 2023-06-08
Primary completion: 2024-05-31
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.